slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
18.560 KRW | -1,43% | -2,47% | -21,52% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 81 029 | 100,0 % | 83 240 | 100,0 % | +2,73% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
95,9
%
| 77 605 | 95,8 % | 79 794 | 95,9 % | +2,82% |
Overseas
4,1
%
| 3 424 | 4,2 % | 3 446 | 4,1 % | +0,65% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eun-Hee Park
CEO | Chief Executive Officer | 57 | - |
Yong-Ki Park
DFI | Director of Finance/CFO | 63 | - |
Seung-Hee Han
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Chan-Bok Lee
SAM | Sales & Marketing | 55 | - |
Byung-Jin Lee
SAM | Sales & Marketing | 65 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jin-Hyoung Kim
BRD | Director/Board Member | 47 | 30-03-22 |
Jae-Don Park
BRD | Director/Board Member | 88 | - |
Eun-Hee Park
CEO | Chief Executive Officer | 57 | - |
Yong-Ki Park
DFI | Director of Finance/CFO | 63 | - |
Won-Myung Park
BRD | Director/Board Member | 65 | - |
Beon-Gil Choi
BRD | Director/Board Member | 49 | 30-03-22 |
Chun-Soo Im
BRD | Director/Board Member | 59 | 30-03-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 906 701 | 3 860 982 ( 35,40 %) | 0 | 35,40 % |
Bedrijfsgegevens
KOREA PHARMA Co., Ltd.
87 Jeyakgongdan 3-gil Hyangnam-eup
18622, Hwaseong-si
+
http://www.koreapharma.co.krSector
Verkoop per regio
Chiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-21,52% | 151 mln. | |
+38,00% | 705 mld. | |
+32,82% | 583 mld. | |
-3,67% | 364 mld. | |
+20,22% | 332 mld. | |
+5,03% | 291 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+8,79% | 169 mld. |
- Beurs
- Aandelen
- Koers A032300
- Onderneming KOREA PHARMA Co., Ltd.